We are live on ! Find out more
ANRO icon

Alto Neuroscience
ANRO

77 hedge funds and large institutions have $95.3M invested in Alto Neuroscience in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 10

3% more funds holding

Funds holding: 75 → 77 (+2)

9% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 22

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.55% less ownership

Funds ownership: 85.09% → 83.54% (-1.5%)

48% less call options, than puts

Call options by funds: $136K | Put options by funds: $260K

64% less capital invested

Capital invested by funds: $265M → $95.3M (-$170M)

Holders
77
Holders Change
+2
Holders Change %
+2.67%
% of All Funds
1.01%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
31
Reduced
10
Closed
22
Calls
$136K
Puts
$260K
Net Calls
-$124K
Net Calls Change
-$3.54M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$6.09M
2
Marshall Wace
Marshall Wace
United Kingdom
+$5.23M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.46M
4
AC
Armistice Capital
New York
+$4.06M
5
WP
Woodline Partners
California
+$3.1M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$23.7M
2
ECM
ExodusPoint Capital Management
New York
-$13.3M
3
Jennison Associates
Jennison Associates
New York
-$9.52M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.85M
5
PFMOSF
Philadelphia Financial Management of San Francisco
California
-$5.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
AWG
1
Alpha Wave Global
New York
$15.7M – – –
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$7.16M +$4.46M +714,461 +73%
BlackRock
3
BlackRock
New York
$6.26M +$214K +34,280 +2%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.35M -$6.85M -1,097,510 -46%
Vanguard Group
5
Vanguard Group
Pennsylvania
$5.2M -$274K -43,848 -3%
Franklin Resources
6
Franklin Resources
California
$4.92M -$363K -58,104 -5%
Citadel Advisors
7
Citadel Advisors
Florida
$4.13M +$6.09M +975,986 New
VPC
8
Vestal Point Capital
New York
$3.87M +$1.65M +265,000 +41%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$3.58M +$227K +36,319 +4%
Marshall Wace
10
Marshall Wace
United Kingdom
$3.54M +$5.23M +837,374 New
AIC
11
AWM Investment Company
New York
$2.91M +$799K +128,100 +23%
7IH
12
72 Investment Holdings
Connecticut
$2.82M – – –
AC
13
Armistice Capital
New York
$2.75M +$4.06M +650,000 New
WP
14
Woodline Partners
California
$2.63M +$3.1M +496,976 +398%
Northern Trust
15
Northern Trust
Illinois
$2.48M +$2.44M +390,190 +198%
Alkeon Capital Management
16
Alkeon Capital Management
New York
$2.02M -$2.86M -457,803 -49%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$2M +$16.7K +2,669 +0.6%
UBS Group
18
UBS Group
Switzerland
$1.7M +$2.29M +367,389 +1,049%
CF
19
Cantor Fitzgerald
New York
$1.57M +$2.34M +375,000 New
IC
20
Ikarian Capital
Texas
$1.48M +$2.18M +350,000 New
State Street
21
State Street
Massachusetts
$1.44M +$642K +102,849 +43%
IHAM
22
Integral Health Asset Management
New York
$1.27M +$1.87M +300,000 New
AC
23
Almitas Capital
California
$1.13M +$1.67M +266,912 New
O
24
OrbiMed
New York
$1.06M +$1.56M +250,000 New
Morgan Stanley
25
Morgan Stanley
New York
$857K +$789K +126,480 +166%
1
2 3 4

ANRO Hedge Fund Activity: Q4 2024 in Review

77 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Alto Neuroscience (ANRO) for Q4 2024, worth a combined $95.3M — down 64% from $265M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new ANRO positions and 22 closed out — a net gain of 2 holders — while 31 added to existing stakes and 10 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $6.09M. The largest seller was RA Capital Management, exiting entirely with an estimated $23.7M sold.

  • 77 institutional investors held Alto Neuroscience (ANRO) as of Q4 2024, up from 75 in Q3 2024.
  • Funds reported $95.3M of Alto Neuroscience stock for Q4 2024, down 64% quarter-over-quarter.
  • 24 funds opened new Alto Neuroscience positions in Q4 2024 and 22 closed out, a net change of +2 holders.
  • The largest Alto Neuroscience buyer in Q4 2024 was Citadel Advisors, an estimated $6.09M added.
  • The largest Alto Neuroscience seller in Q4 2024 was RA Capital Management, an estimated $23.7M sold.

Based on aggregated 13F filings for Q4 2024.